HEARTBEAM, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- HEARTBEAM, INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $10.27M, a 2181.11% increase year-over-year.
- HEARTBEAM, INC. stock issued during period, value, new issues for the quarter ending 2025-12-31 was $10.25M, a 1467.13% increase year-over-year.
- HEARTBEAM, INC. stock issued during period, value, new issues for the quarter ending 2025-09-30 was -$10.25M.
- HEARTBEAM, INC. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $450.00K, a 492.11% increase year-over-year.
- HEARTBEAM, INC. stock issued during period, value, new issues for fiscal 2025 was $10.25M, a 1304.11% increase from fiscal 2024.
- HEARTBEAM, INC. stock issued during period, value, new issues for fiscal 2024 was $730.00K, a 97.05% decline from fiscal 2023.
- HEARTBEAM, INC. stock issued during period, value, new issues for fiscal 2023 was $24.76M, a 2980.10% increase from fiscal 2022.
- HEARTBEAM, INC. stock issued during period, value, new issues for fiscal 2022 was $804.00K, a 94.36% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $10.27M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $10.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $10.25M 10-K · filed 2026-03-12 |
| 2025-09-30 | -$10.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.10M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $450.00K 10-Q · filed 2026-08-13 | $11.35M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $10.25M 10-Q · filed 2026-05-13 | $10.98M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $654.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $730.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | |
| 2024-06-30 | $76.00K 10-Q · filed 2024-08-14 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $24.76M 10-K · filed 2025-03-13 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $24.76M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $24.27M 10-Q · filed 2024-08-14 | $24.76M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $494.00K 10-Q · filed 2024-05-09 | $494.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $804.00K 10-K · filed 2024-03-20 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | |
| 2022-03-31 | $804.00K 10-Q · filed 2023-05-11 | |
| 2021-12-31 | $14.26M 10-K · filed 2023-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |